RA Capital Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,105,213
| Closed | -$27.3M | – | 67 |
|
|
2025
Q1 | $27.3M | Hold |
5,105,213
| – | – | 0.46% | 34 |
|
|
2024
Q4 | $45.6M | Hold |
5,105,213
| – | – | 0.61% | 35 |
|
|
2024
Q3 | $56.2M | Buy |
5,105,213
+61,457
| +1% | +$677K | 0.65% | 34 |
|
|
2024
Q2 | $45.9M | Buy |
5,043,756
+630,606
| +14% | +$5.74M | 0.61% | 40 |
|
|
2024
Q1 | $62.1M | Buy |
+4,413,150
| New | +$62.1M | 0.79% | 34 |
|
|
2022
Q3 | – | Sell |
-760,857
| Closed | -$2.28M | – | 83 |
|
|
2022
Q2 | $2.28M | Sell |
760,857
-501,336
| -40% | -$1.5M | 0.06% | 78 |
|
|
2022
Q1 | $8.47M | Hold |
1,262,193
| – | – | 0.18% | 81 |
|
|
2021
Q4 | $6.8M | Hold |
1,262,193
| – | – | 0.12% | 89 |
|
|
2021
Q3 | $11.2M | Buy |
1,262,193
+270,883
| +27% | +$2.39M | 0.15% | 71 |
|
|
2021
Q2 | $12.6M | Buy |
+991,310
| New | +$12.6M | 0.2% | 66 |
|